I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 8 studies | 26% ± 5% | |
| endothelial cell | 7 studies | 24% ± 11% | |
| myofibroblast cell | 6 studies | 21% ± 3% | |
| connective tissue cell | 6 studies | 24% ± 8% | |
| pericyte | 6 studies | 35% ± 12% | |
| smooth muscle cell | 6 studies | 23% ± 8% | |
| natural killer cell | 6 studies | 21% ± 3% | |
| glutamatergic neuron | 5 studies | 34% ± 19% | |
| neuron | 4 studies | 32% ± 16% | |
| epithelial cell | 4 studies | 37% ± 17% | |
| hematopoietic precursor cell | 3 studies | 27% ± 7% | |
| conventional dendritic cell | 3 studies | 25% ± 7% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 18% ± 3% | |
| non-classical monocyte | 3 studies | 21% ± 3% | |
| retinal ganglion cell | 3 studies | 54% ± 26% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 21% ± 3% | |
| macrophage | 3 studies | 20% ± 5% | |
| amacrine cell | 3 studies | 38% ± 10% | |
| oligodendrocyte precursor cell | 3 studies | 22% ± 3% | |
| intestinal crypt stem cell | 3 studies | 16% ± 1% | |
| CD8-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| plasmacytoid dendritic cell | 3 studies | 22% ± 3% |
